![](https://cdn.prod.website-files.com/631715a39beb052fc70c9374/63978086afbf9b0d5861a0f3_PLOS-ONE_logo_nobug.png)
Assessing the performance of genome-wide association studies for predicting disease risk.
12/5/19
"Multi-omics is a much more accurate and reliable predictor of whether a patient will develop a disease in the future than genomics'
Explore our science in detail.
"Multi-omics is a much more accurate and reliable predictor of whether a patient will develop a disease in the future than genomics'
"Health risks associated with type 2 diabetes and associated diseases were reduced after 100 days of personalized lifestyle recommendations"
"New techniques are making metabolomics increasingly useful for a wider range of biomedical and pharmaceutical applications"
Advisory board